Home News

ROVI completes the manufacture of the first batches of Moderna vaccine

Laboratorios Farmacéuticos Rovi, S.A. (BME -Spanish Stock Exchanges and Markets: ROVI), a pan-European specialised company engaged in the research, development and marketing of biological specialties and a manufacturer with a high degree of technological

Wed, 13/01/2021 - 17:03 0 min
Download related document
No votes yet
 
Related
ROVI participates in the manufacture of the active substance of Moderna’s COVID...
Laboratorios Farmacéuticos Rovi, S.A. (BME: ROVI), a pan-European pharmaceutical company specializing and engaging in the research,...
2 min
12/04/2021
Full Year 2020 Results Press Release
0 min
24/02/2021
ROVI achieves a 10% increase in operating income and 55% in net profit
ROVI achieves a 10% increase in operating income and 55% in net profit
Laboratorios Farmacéuticos Rovi, SA (BME: ROVI), company Pan-European pharmaceutical company specialized and dedicated to the research,...
5 min
24/02/2021